Capricor Therapeutics is trading 5% down now at $8.21, with no new company announcement directly explaining the September 10 decline; broader markets are weaker after hotter producer inflation raised rate concerns and Middle East tensions kept oil above $100.
- Shares declined 4.64% to $8.64 on September 9.
- Major indexes are down more than 0.5%; recent securities-fraud lawsuit reminders may also weigh on sentiment.